Case Report Open Access
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Aug 6, 2021; 9(22): 6552-6556
Published online Aug 6, 2021. doi: 10.12998/wjcc.v9.i22.6552
Spontaneous rupture of adrenal myelolipoma as a cause of acute flank pain: A case report
Dong Soo Kim, Jeong Woo Lee, Sang Hyub Lee, Department of Urology, School of Medicine, Kyung Hee University, Seoul 02447, South Korea
ORCID number: Dong Soo Kim (0000-0002-5696-0671); Jeong Woo Lee (0000-0002-4508-8240); Sang Hyub Lee (0000-0002-4509-5846).
Author contributions: Kim DS, Lee JW, and Lee SH contributed equally to this work; Lee JW and Lee SH designed the research study; Kim DS and Lee JW performed the research; Kim DS and Lee SH wrote the manuscript; all authors have read and approve the final manuscript.
Supported by a National Research Foundation of Korea (NRF) Grant Funded by the Korean Government (Ministry of Science and ICT), No. 2019R1G1A1100422.
Informed consent statement: This study was approved by the Institutional Review Board of Kyung Hee University Hospital (IRB file No. KHUH 2021-02-014). Patient consent was waived due to the retrospective design of the study and its application of standard practice.
Conflict-of-interest statement: The authors have no potential conflicts of interest to declare.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Sang Hyub Lee, MD, PhD, Associate Professor, Department of Urology, School of Medicine, Kyung Hee University, Kyung Hee University Medical Center 23, Kyung Hee Dae-ro, Dongdaemun-gu, Seoul 02447, South Korea. uroshlee@khu.ac.kr
Received: April 9, 2021
Peer-review started: April 9, 2021
First decision: April 23, 2021
Revised: May 2, 2021
Accepted: May 15, 2021
Article in press: May 15, 2021
Published online: August 6, 2021
Processing time: 109 Days and 13 Hours

Abstract
BACKGROUND

Adrenal myelolipoma is a rare, benign, non-functioning mass that occurs in the adrenal gland. It is composed of an admixture of hematopoietic elements and mature adipose tissue, similar to bone marrow. Even at large sizes, adrenal myelolipomas are usually asymptomatic and often incidentally found by ultrasonography or computed tomography (CT) scan. This paper describes an unusual case of adrenal myelolipoma presenting as flank pain.

CASE SUMMARY

A 50-year-old male with severe right flank pain underwent a CT scan revealing a huge mass extending into the suprarenal space. The mass showed a fat component with retroperitoneal hemorrhage. The tumor was treated laparoscopically, and pathologic examination revealed features of myelolipoma originating from the adrenal gland.

CONCLUSION

Adrenal myelolipomas are generally asymptomatic and can be treated conservatively. However, rupture and hemorrhage of the tumor can cause symptoms requiring surgical removal.

Key Words: Adrenal neoplasms; Myelolipoma; Adrenal glands; Case report

Core Tip: Adrenal myelolipomas are rare, benign, non-functioning masses that are generally asymptomatic. They can be managed conservatively, but in symptomatic cases with rupture or hemorrhage, surgical removal may be required. This article presents a rare case of adrenal myelolipoma rupture requiring laparoscopic excision with a review of literature on this subject.



INTRODUCTION

Adrenal myelolipoma is a rare, benign, non-functioning mass of the adrenal gland. It is composed of an admixture of hematopoietic elements and mature adipose tissue, similar to the elements of the bone marrow[1]. The name myelolipoma was given to the tumor by Oberling[2] in 1929. Myelolipomas can occur at various sites, especially in the retroperitoneum, pelvis, mediastinum, and paravertebral region[3]. To our knowledge, very few cases of adrenal myelolipoma have been reported. Recently, we treated a complicated case of a ruptured huge adrenal myelolipoma. This paper discusses our experience and provides a short review of the literature.

CASE PRESENTATION
Chief complaints

A 50-year-old man visited the department of emergency medicine complaining of severe right flank pain.

History of present illness

He had no recent history of trauma or injuries to his abdomen or right flank. The pain had started a few hours before arriving at the emergency department and it could not be relieved with generic over-the-counter pain killers.

History of past illness

Review of the patient’s past medical history revealed nothing significant. He had no history of receiving any surgeries or medical procedures.

Personal and family history

The patient could not remember any remarkable medical history of his parents and siblings.

Physical examination

On physical examination, he had severe tenderness at the right costovertebral angle. There was no discoloration of the skin and no traumatic wounds or lesions were observed. He described having a severe flank pain that he could not accurately localize. The pain had abruptly started a few hours ago and it had not subsided with medication. It was distinct from pain caused by ureteral stones, which would have been acute, colicky, and more responsive to analgesics. The patient’s vital signs were stable, though he was slightly tachycardic.

Laboratory examinations

His hemoglobin level was normal and did not change after the first day. Although the computed tomography (CT) findings were consistent with adrenal myelolipoma, we assessed his hormone levels to rule out other hormonally active tumors, and all results were within normal limits.

Imaging examinations

CT scan showed a huge mass in the right suprarenal area, with fat components and retroperitoneal hemorrhage (Figure 1). It was approximately 9 cm with homogeneous adipose density that was not enhanced by contrast media. Hematoma formation due to retroperitoneal hemorrhage from the rupture was observed but no active bleeding or dye leakage was seen. Follow-up CT scan was performed one week later, and no definite change was observed compared to the initial scan.

Figure 1
Figure 1 Computed tomography scan of the adrenal myelolipoma. On computed tomography, adrenal myelolipomas exhibit distinct characteristics, with most of the mass showing fat attenuation. In this case, the tumor was located superior to the right kidney, showing mixed low attenuation due to the fat component and intermediate attenuation because of hemorrhage.
FINAL DIAGNOSIS

The final diagnosis of the patient was a ruptured right adrenal myelolipoma. Pathologic examination after surgery revealed the typical findings of an adrenal myelolipoma with hematoma (Figures 2 and 3) and confirmed our diagnosis.

Figure 2
Figure 2 Macroscopic view of the resected tumor . The tumor consisted of mainly of yellowish fat tissue. However, the capsule was ruptured, and hemorrhage was observed, consistent with the computed tomography scan.
Figure 3
Figure 3 Pathologic findings of the specimen (magnification, × 100). The specimen showed a mixture of mature adipose tissue and hematopoietic elements.
TREATMENT

After consulting with the patient, laparoscopic surgical excision was performed to remove the ruptured adrenal myelolipoma.

OUTCOME AND FOLLOW-UP

The patient recovered from surgery without complications and no other problems were observed during follow-up.

DISCUSSION

Knowledge of this tumor type remains suboptimal because of its rarity. There are multiple theories concerning the development and etiology of adrenal myelolipomas, including extramedullary hematopoiesis by autonomous proliferation of bone marrow cells transferred during embryogenesis, development from embryonic rests of primitive mesenchymal stem cells, embolism of bone marrow lodging in the adrenal gland, and adrenocortical cell metaplasia of the reticuloendothelial cells of blood capillaries in response to stimuli such as necrosis, infection, or stress[3].

Adrenal myelolipoma is most often an asymptomatic, benign, and hormonally inactive tumor[4-7]. Some studies have shown gender predilection, but there is no statistically significant difference in the incidence between males and females overall. The disease is usually unilateral, with preference for the right side[4,5]. Almost all detailed cases, except extremely huge tumors, were diagnosed by CT scan. Because of the high adipose character of the tumor, CT features are remarkable. The CT value is usually less than -30 Hounsfield units (HU) and is often as low as -100 HU[8]. On magnetic resonance imaging (MRI), the fatty component of this tumor is hyperintense on non-fat-suppressed T1-weighted images. The use of fat suppression can help confirm the diagnosis by demonstrating a loss of signal intensity within the fatty component. MRI is the most sensitive and specific modality for diagnosing adrenal hemorrhage[8]. Therefore, when adrenal myelolipoma is difficult to confirm with CT scan, MRI can provide useful information. However, tumors with minimal adipose tissue or hemorrhage can be more difficult to characterize. Although not usually required, fine needle aspiration (FNA) biopsy can confirm the diagnosis. Upon air-dried May-Grunwald-Giemsa staining, the FNA material reveals hematopoietic precursors including megakaryocytes, myeloid elements of varying stages of maturation, and fat vacuoles, with adrenal cortical cells in the background[9].

Despite numerous studies on adrenal myelolipomas, there is no universally accepted treatment to manage this tumor. Meyer and Behrend[6] concluded that patients with large, asymptomatic tumors greater than 10 cm should be treated surgically because of the risk of abdominal pain or life-threatening shock caused by spontaneous hemorrhage. Even in cases of small, asymptomatic, incidentally discovered adrenal lesions, some studies have recommended long-term follow-up because interval growth has been reported[10]. However, Han et al[11] insisted that not all tumors should be resected, and that almost none of the tumors grow. They decided to perform surgical resection only in the presence of symptoms, regardless of mass size. Even though each report reached different conclusions, resection of symptomatic adrenal myelolipomas is an acceptable treatment method.

The majority of adrenal myelolipomas is “silent” tumors with no hormonal activity; however, some cases with hormonal abnormality have been noted. Wagnerová et al[7] and Liu et al[12] reported cases of adrenal myelolipomas with hormonal activities. Therefore, patients diagnosed with adrenal myelolipomas on radiologic evaluation and who have other medical problems should be evaluated to detect abnormal hormonal activity.

CONCLUSION

Adrenal myelolipoma is generally a benign and non-functional tumor. If the tumor is asymptomatic and is characteristic on CT scan, it can be treated conservatively. However, if a patient presents with severe symptoms, the tumor must be removed surgically. Based on our experience, surgical intervention can be easily conducted with a laparoscopic approach, even when the tumor has caused hemorrhage.

Footnotes

Manuscript source: Unsolicited manuscript

Specialty type: Urology and nephrology

Country/Territory of origin: South Korea

Peer-review report’s scientific quality classification

Grade A (Excellent): 0

Grade B (Very good): B, B

Grade C (Good): C

Grade D (Fair): 0

Grade E (Poor): 0

P-Reviewer: Marickar F, Mu PY, Naem A S-Editor: Yan JP L-Editor: A P-Editor: Wang LL

References
1.  Gierke E. Uber Knochenmarksgewebe in der Nebenniere. Beitr Path Anat Supple. 1905;311.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Oberling C. Les formations myelo-lipomateuses. Bull Assoc Fr Cancer. 1929;234.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Decmann Á, Perge P, Tóth M, Igaz P. Adrenal myelolipoma: a comprehensive review. Endocrine. 2018;59:7-15.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 64]  [Cited by in F6Publishing: 76]  [Article Influence: 12.7]  [Reference Citation Analysis (0)]
4.  Bokhari MR, Zulfiqar H, Garla VV.   Adrenal Myelolipoma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2021.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Hsu SW, Shu K, Lee WC, Cheng YT, Chiang PH. Adrenal myelolipoma: a 10-year single-center experience and literature review. Kaohsiung J Med Sci. 2012;28:377-382.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 15]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
6.  Meyer A, Behrend M. Presentation and therapy of myelolipoma. Int J Urol. 2005;12:239-243.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 36]  [Cited by in F6Publishing: 39]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
7.  Wagnerová H, Lazúrová I, Bober J, Sokol L, Zachar M. Adrenal myelolipoma. 6 cases and a review of the literature. Neoplasma. 2004;51:300-305.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 69]  [Cited by in F6Publishing: 69]  [Article Influence: 3.5]  [Reference Citation Analysis (0)]
8.  Guo YK, Yang ZG, Li Y, Deng YP, Ma ES, Min PQ, Zhang XC. Uncommon adrenal masses: CT and MRI features with histopathologic correlation. Eur J Radiol. 2007;62:359-370.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 100]  [Cited by in F6Publishing: 86]  [Article Influence: 5.1]  [Reference Citation Analysis (0)]
9.  Osborn M, Smith M, Senbanjo T, Crofton M, Robinson S, Rajan P. Adrenal myelolipoma - clinical, radiological and cytological findings: a case report. Cytopathology. 2002;13:242-246.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 15]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
10.  Gershuni VM, Bittner JG 4th, Moley JF, Brunt LM. Adrenal myelolipoma: operative indications and outcomes. J Laparoendosc Adv Surg Tech A. 2014;24:8-12.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 17]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
11.  Han M, Burnett AL, Fishman EK, Marshall FF. The natural history and treatment of adrenal myelolipoma. J Urol. 1997;157:1213-1216.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 5]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
12.  Liu N, Zhang W, Tan J, Zhou J, Yu X, Ren N, Fang Z, Jiao W, Fan Y, Liu C. Adrenal myelolipoma with hyperandrogenemia and schizophrenia. Cancer Manag Res. 2018;10:177-180.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in F6Publishing: 4]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]